6 results on '"Jo Ann A Giaconi"'
Search Results
2. American Glaucoma Society Position Paper: Microinvasive Glaucoma Surgery
- Author
-
Ronald L. Fellman, Brian J. Song, Brian E. Flowers, Joshua D. Stein, Brian A. Francis, Arsham Sheybani, Kuldev Singh, Alan L. Robin, Jo Ann A. Giaconi, Michelle R. Butler, Cynthia Mattox, and Manjool Shah
- Subjects
Position statement ,Consensus ,medicine.medical_treatment ,MEDLINE ,Glaucoma ,Ophthalmologic Surgical Procedures ,01 natural sciences ,Article ,Food and drug administration ,03 medical and health sciences ,0302 clinical medicine ,Glaucoma surgery ,Medicine ,Humans ,0101 mathematics ,Glaucoma Drainage Implants ,Societies, Medical ,Medical education ,business.industry ,Task force ,010102 general mathematics ,General Medicine ,medicine.disease ,United States ,Ophthalmology ,030221 ophthalmology & optometry ,Position paper ,Professional association ,business - Abstract
In 2018, the American Glaucoma Society (AGS), the world’s largest professional society of glaucoma subspecialists, convened a 12-member task force of experts to craft a position statement about microinvasive glaucoma surgery (MIGS). The main objective of this position statement is to provide a succinct overview of these procedures and to address some misconceptions about MIGS. The members of the task force were selected by the AGS Board of Directors and include AGS members with expertise in developing MIGS, teaching MIGS, performing research on use and outcomes of these procedures, and working with the United States Food and Drug Administration (FDA) and other regulatory agencies about developing criteria to evaluate the efficacy and safety of these devices. Each of the sections of the position statement was prepared by subgroups of the task force, and then the material from the various sections was aggregated, and the leader of the task force (J.D.S.) merged the material into a cohesive draft. This draft was shared with the AGS Executive Committee and other members of the AGS Board of Directors for additional input.
- Published
- 2020
3. Ophthalmology Objectives for Medical Students: Revisiting What Every Graduating Medical Student Should Know
- Author
-
Emily B. Graubart, Susan H. Forster, Anju Goyal, Rukhsana G. Mirza, Jo Ann A. Giaconi, Prithvi S. Sankar, Evan L. Waxman, and Jamie B. Rosenberg
- Subjects
Medical education ,Students, Medical ,020205 medical informatics ,business.industry ,02 engineering and technology ,03 medical and health sciences ,Ophthalmology ,0302 clinical medicine ,030221 ophthalmology & optometry ,0202 electrical engineering, electronic engineering, information engineering ,Medicine ,Humans ,Clinical Competence ,Educational Measurement ,business ,Education, Medical, Undergraduate - Published
- 2018
4. Voriconazole and Fungal Keratitis: A Report of Two Treatment Failures
- Author
-
Fabiana B. Marangon, Jo Ann A. Giaconi, Eduardo C. Alfonso, and Darlene Miller
- Subjects
Male ,Antifungal Agents ,Corneal Infection ,Administration, Topical ,Colletotrichum dematium ,Microbial Sensitivity Tests ,Treatment failure ,Microbiology ,Keratitis ,Fusarium ,Fusarium oxysporum ,Colletotrichum ,medicine ,Humans ,Pharmacology (medical) ,Fungal keratitis ,Treatment Failure ,Aged, 80 and over ,Pharmacology ,Voriconazole ,biology ,food and beverages ,Middle Aged ,Triazoles ,medicine.disease ,biology.organism_classification ,Ophthalmology ,Pyrimidines ,Mycoses ,medicine.drug - Abstract
Two cases of fungal keratitis, one caused by Fusarium oxysporum and the other by Colletotrichum dematium, that failed treatment with topical voriconazole 1% are presented. These cases are noteworthy in that topical voriconazole was unable to eradicate the corneal infection in both cases, despite relatively low MIC90 tested for each species of 8 and 1 microg/mL, respectively.
- Published
- 2006
- Full Text
- View/download PDF
5. Long-term results of thin corneas after refractive laser surgery
- Author
-
Vasilios F. Diakonis, Sonia H. Yoo, Jo Ann A. Giaconi, Eirineos Gkenos, Dimitrios I. Bouzoukis, Aristofanis I. Pallikaris, George D. Kymionis, and Nikolaos S. Tsiklis
- Subjects
Laser surgery ,Adult ,Male ,medicine.medical_specialty ,Time Factors ,genetic structures ,Adolescent ,medicine.medical_treatment ,Keratomileusis, Laser In Situ ,Keratomileusis ,Photorefractive Keratectomy ,Cornea ,Ophthalmology ,medicine ,Myopia ,Humans ,Postoperative Period ,Corneal pachymetry ,Dioptre ,Ultrasonography ,medicine.diagnostic_test ,business.industry ,LASIK ,Corneal Topography ,Long term results ,Middle Aged ,eye diseases ,Photorefractive keratectomy ,Surgery ,medicine.anatomical_structure ,Treatment Outcome ,Female ,Lasers, Excimer ,sense organs ,business ,Tomography, Optical Coherence ,Follow-Up Studies - Abstract
Purpose To report the long-term refractive results of photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) in patients with thin corneas. Design A long-term, retrospective, non-randomized follow-up study. Methods Sixty-three patients (124 eyes) (28 males and 35 females), who had a preoperative central corneal thickness (CCT) of less than 500 microns and completed at least one year of follow-up examinations after surgery. Thirty-five patients (68 eyes) underwent PRK and 28 patients (56 eyes) underwent LASIK. Results Mean preoperative corneal pachymetry was 484.95 ± 6.65 μm (range, 470 to 498 μm) and 482.38 ± 10.73 μm (range, 453 to 499 μm) for LASIK and PRK, respectively. No intraoperative complications were found in both groups. None of the included eyes developed postrefractive corneal ectasia. The mean predictability for the PRK group was 0.08 diopters (D) with a standard deviation of 0.40 D (range, −1.38 to 1.00 D), and the mean predictability for the LASIK group was 0.14 D with a standard deviation of 0.55 D (range, −1.25 to 1.33 D). Conclusions Refractive laser surgery with LASIK or PRK in patients with thin corneas (less than 500 μm) seems to be a safe and predictable technique for myopic refractive corrections.
- Published
- 2007
6. Asymmetries and Visual Field Summaries as Predictors of Glaucoma in the Ocular Hypertension Treatment Study
- Author
-
Mary B. Hall, John M. Ramocki, Jody R. Piltz-Seymour, Donald F. Everett, Lea Morton, Robert A. Copeland, Stacey S. Goldstein, Michele C. Lim, Harry A. Quigley, Silvia Orengo-Nania, Bernard Becker, Heather Johnson, Richard K. Parrish, Manju Sharma, Teresa A. Long, Karen Clark, David S. Friedman, Cheryl L. Vitelli, Ditte J. Hess, Annisa L. Jamil, Michael A. Kass, Fermin P. Ballesteros, Lisa Levin, Fortunata Darmody, Carol J. Pollack-Rundle, Hina N. Ahmed, Celso Tello, Shan C. Lin, Maria Cristina Wells-Albornoz, Robb R. Shrader, Laura L. Schulz, Betsy Hornbeck, Ellen Long, Donald J. Zack, Jo Anne Katz, Nina C. Mondoc, Kathleen A. Lamping, Robert J. Derick, Julia A. Beiser, Felicia Keel, Kathryn R. Sherman, Allan J. Flach, John Connett, Alan L. Robin, Ronald L. Gross, Jeffrey M. Liebmann, Joern B. Soltau, Sandy Lear, Terry J. Bergstrom, Ramzi Hemady, Denise M. Owensby, William M. Bourne, Janice T. Petner, Arthur L. Schwartz, Shannan E. Bandermann, Ruth Vandenbroucke, Michelle A. Tehranisa, James D. Brandt, Linda M. Zangwill, Douglas R. Anderson, Valerie Margol, Charles J. Patorgis, Robert Ritch, Ingrid J. Clark, Allan E. Kolker, Osaro A. Okuonghae, John M. O'Grady, Joyce C. Schiffman, Y. P. Dang, Deborah Lee, Melanie Gutkowski, Robin L. Montgomery, Sayoko E. Moroi, Mark B. Sherwood, Rachel Scott, Simon K. Law, Deborah Darnley-Fisch, Mark S Juzych, Eydie Miller, Donald L. Budenz, Camilele M. Hylton, Keri Dirkes, N. Douglas Baker, Steven J. Gedde, Donald A. Abrams, Kimberly E. Cello, Deborah A. Dunn, Pamela M. Frady, Steven L. Mansberger, George A. Cioffi, Paul McManus, Deborah L. Simon, Bettina J. Modica, John L. Keltner, Emily L. Patterson, Myron Yanoff, Marianne L. Perry, Juanjuan Fan, Nancy J. Tvedt, Jean L. Walker, Shelly R. Smith, Kathyrne McKinney, Aldo Fantin, Dale K. Heur, Benita D. Slight, Karen D. Schacht, Francisco Fantes, Mark L. McDermott, Pamela A. Sample, Anjali M. Bhorade, Thomas S. Harbin, Carla J. Siegfried, Salvador Murillo, J. Philip Miller, Shaban Demirel, Marilyn A. Sponzo, Patricia A. Morris, Linda A. Van Conett, Eve J. Higginbotham, Barry R Davis, Michael V. Drake, Sheila M. Rock, Nauman R. Imami, Donna Leef, Madeline L. Del Calvo, Howard S. Weiss, J. Rigby Slight, Cheryl McGill, William J. Feuer, Anne L. Coleman, Dale K. Heuer, Juan Allen, David M. Lehmann, Edward M. Barnett, Clete Clark, Claude L Cowan, Jo Anne M Fraser, Irvin P. Pollack, Chris A. Johnson, Paul Weber, Mary Jameson, Jo Ann A Giaconi, Ivan R. Schwab, Sandra Quirin, David C. Herman, Montana L. Hooper, Judit Mohay, Steven M. Kymes, Bhupinder S. Dhillon, Julie M. Wright, Elizabeth Carnegie, Becky A. Nielsen, Ronald Munson, Monica Y. Allen, Teresa A. Roediger, M. Roy Wilson, G. Richard Bennett, Robert N. Weinreb, John A. Keltner, Allen D. Beck, Mary Bednarski, Henry D. Jampel, Christina A. Bruno, Bobbie Ballenberg, Kevin L. Powdrill, Anastasias Costarides, Anne M. Boeckl, Prithvi S. Sankar, Richard S. Baker, Robyn Priest-Reed, Douglas E. Gaasterland, Gregory L. Skuta, Lindsay C. Bennett, Jeffrey J. Casper, Frank S. Ashburn, Diane Moore, Nathan Congdon, Bret A Hughes, Mae E. Gordon, Robert L. Stamper, Douglas H. Johnson, and Richard A. Levine
- Subjects
Male ,Intraocular pressure ,Time Factors ,genetic structures ,Open angle glaucoma ,Eye disease ,Vision Disorders ,Ocular hypertension ,Glaucoma ,Article ,Risk Factors ,medicine ,Psychophysics ,Humans ,Antihypertensive Agents ,Intraocular Pressure ,Monocular ,business.industry ,Middle Aged ,Prognosis ,medicine.disease ,eye diseases ,Visual field ,Visual Field Tests ,Optometry ,Female ,Ocular Hypertension ,sense organs ,Visual Fields ,business ,Glaucoma, Open-Angle - Abstract
To evaluate whether baseline visual field data and asymmetries between eyes predict the onset of primary open-angle glaucoma (POAG) in Ocular Hypertension Treatment Study (OHTS) participants.A new index, mean prognosis (MP), was designed for optimal combination of visual field thresholds, to discriminate between eyes that developed POAG from eyes that did not. Baseline intraocular pressure (IOP) in fellow eyes was used to construct measures of IOP asymmetry. Age-adjusted baseline thresholds were used to develop indicators of visual field asymmetry and summary measures of visual field defects. Marginal multivariate failure time models were constructed that relate the new index MP, IOP asymmetry, and visual field asymmetry to POAG onset for OHTS participants.The marginal multivariate failure time analysis showed that the MP index is significantly related to POAG onset (P0.0001) and appears to be a more highly significant predictor of POAG onset than either mean deviation (MD; P = 0.17) or pattern standard deviation (PSD; P = 0.046). A 1-mm Hg increase in IOP asymmetry between fellow eyes is associated with a 17% increase in risk for development of POAG. When threshold asymmetry between eyes existed, the eye with lower thresholds was at a 37% greater risk of development of POAG, and this feature was more predictive of POAG onset than the visual field index MD, though not as strong a predictor as PSD.The MP index, IOP asymmetry, and binocular test point asymmetry can assist in clinical evaluation of eyes at risk of development of POAG.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.